04.23.25 -- The Forgotten Factor In CDMO Success

This webinar explores 3D screen printing in pharmaceutical manufacturing, a breakthrough overcoming scalability and formulation challenges of traditional 3D printing. It enables precise layering for multi-functional tablets with customizable drug release profiles, enhancing efficacy and patient convenience. Attendees will learn how this cost-effective, scalable technology optimizes pharmacokinetics, reduces API use, and offers new IP opportunities. Click here to learn more.

Consider the advantages of outsourcing equipment calibration to ISO 17025-accredited suppliers, including cost efficiency and regulatory assurance, in our detailed analysis.

Determining a drug candidate’s probability of commercial success is a significant phase in the drug development process. Understand that there is no room for error.

Discover five key factors that drive a seamless and efficient technology transfer, highlighting how a culture of technical expertise, customer focus, and operational flexibility is crucial to success.

A typical life sciences enterprise now has 500+ software applications. A digital adoption platform (DAP) is an overlay to help with user adoption, like an advanced version of the MS Word "paperclip" assistant.

This paper presents three approaches to address poor solubility in organic solvents for spray drying as well as case studies outlining their successful application during development.

An increasing number of poorly soluble APIs are the cornerstone of cutting-edge therapies, necessitating equally complex formulation technologies to maintain or improve solubility and, ultimately, bioavailability.

To meet ambitious orphan drug development timelines, CDMOs must be able to scale quickly to progress from early clinical development to validation and commercial launch.

Discover how CDMOs can help you achieve and maintain CMC compliance throughout the drug development lifecycle. Outsourced Pharma Live will explore how to leverage CDMO expertise in process optimization, documentation, and regulatory submissions. Learn practical strategies to align your CMC goals with CDMO capabilities to accelerate development and ensure successful drug launches.

See why oral administration remains the most widely used route for the successful delivery of active pharmaceuticals to patients.

A CDMO with the right team of experts can aid drug development, regulatory compliance, and clinical trial supply, accelerating timelines to first human dose clinical trials and the path to market.

As a leading partner in ocular therapy, Altasciences' integrated CRO/CDMO solutions can support your ophthalmic drug development program from lead candidate selection to market.